FDA Conditionally Grants Occlutech an IDE for PFO Study in U.S.
Patient enrollment is expected to commence during the second half of 2021. The study's primary and secondary endpoints, PFO Closure and recurrent stroke, respectively, will be evaluated at the 12-month patient follow-up.
BrainQ $40M Funding Round to Support Multicenter Pivotal Trial
The funding will be used to support a multicenter pivotal trial for its groundbreaking technology for ischemic stroke survivors in selected US hospitals.
Tips On How To Use Alternative Medication To Better Your Life
Conventional medicine has a lot of benefits. Whether it’s radiology, diagnostics, surgery, or medication, conventional Western medicine can alleviate many of humanity’s biggest health...
William Starling Joins the Accumed Radial Board of Directors
Starling is managing Director of Synergy Life Science Partners, LP, a $143 million Venture Capital Partnership, and Chief Executive Officer of Synecor, LLC (Synecor), a business generator of new Life Science companies based in Research Triangle Park, North Carolina.
Leading Diabetes Advocacy Groups Urge CDC to Include Americans with Diabetes in Those Prioritized for COVID-19 Vaccine Boosters
“There are two issues here,” said Dr. Robert Gabbay, Chief Scientific and Medical Officer for the ADA. “First, you must consider the population of patients who are most at risk from contracting the COVID-19 virus. Thus far, this has been the focus of the CDC and the FDA.”